Appeal No. 2006-0632 Παγε 6
Application No. 09/929,665
to the . . . antigens identified by the monoclonal antibodies of the present invention,” we
conclude that appellant’s disclosure as a whole reasonably conveys to one of skill in the
art that appellant was in possession of “[a]n isolated antibody or antigen binding portion
thereof which competes for binding to prostate specific membrane antigen [ ] with a
monoclonal antibody selected from the group consisting of an E99, a J415, a J533 and
a J591 monoclonal antibody” (claim 144), as of the filing date of this application.
The rejection of claims 144, 156-168 and 170-210 under the first paragraph of 35
U.S.C. § 112 is reversed.
REVERSED
)
Toni R. Scheiner )
Administrative Patent Judge )
)
)
) BOARD OF PATENT
)
Demetra J. Mills ) APPEALS AND
Administrative Patent Judge )
) INTERFERENCES
)
)
)
Eric Grimes )
Administrative Patent Judge )
Page: Previous 1 2 3 4 5 6 7 8 Next
Last modified: November 3, 2007